Cat. No.: DIA-0243106
Product Information | |
---|---|
CAS No. | 863004-48-2 |
Formula | C17H17NOS |
Molecular Weight | 283.39 |
SMILES | O=C1CC(C)SC2=CC=CC=C2N1CC3=CC=CC=C3 |
Target | GSK-3 |
Product Description | GSK-3β inhibitor 14 (Compound 6i), benzothiazepinone derivative, is a weak GSK-3β inhibitor (IC50 >100 μM). |
Format & Storage | |
---|---|
Format | Solid |
Color | White to off-white |
Purity | 99.92% |
Shipping | Room temperature in the continental U.S. Other areas may vary. |
Storage | In solvent: -80°C, 6 months; -20°C, 1 month (protect from light) |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.